Handelsbanken Fonder AB - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$253
-24.5%
10,5000.0%0.00%
-50.0%
Q2 2023$335
+16.3%
10,500
+11.7%
0.00%0.0%
Q1 2023$288
-21.7%
9,4000.0%0.00%0.0%
Q4 2022$368
-99.8%
9,400
+113.6%
0.00%
+100.0%
Q3 2022$210,000
-58.8%
4,400
-50.6%
0.00%
-66.7%
Q1 2022$510,000
-28.1%
8,9000.0%0.00%0.0%
Q4 2021$709,000
-0.6%
8,900
+8.5%
0.00%
-25.0%
Q3 2021$713,000
-32.4%
8,2000.0%0.00%
-33.3%
Q2 2021$1,055,000
+96.8%
8,200
+22.4%
0.01%
+100.0%
Q1 2021$536,000
-2.0%
6,7000.0%0.00%0.0%
Q4 2020$547,0006,7000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
HSG Holding Ltd 1,127,934$31,582,0005.60%
Omega Fund Management, LLC 302,821$8,479,0002.32%
Redmile Group, LLC 3,356,958$93,995,0001.74%
BRANDYWINE MANAGERS, LLC 10,875$305,0001.25%
DC Investments Management, LLC 88,100$2,467,0000.91%
Alphabet Inc. 663,691$18,583,0000.86%
Cormorant Asset Management, LP 796,429$22,036,0000.84%
HHLR ADVISORS, LTD. 2,966,403$83,059,0000.76%
Temasek Holdings (Private) Ltd 3,354,641$93,930,0000.56%
Granahan Investment Management 96,598$2,705,0000.10%
View complete list of BEAM THERAPEUTICS INC shareholders